Trade Mark Journal No.2026/017 24 April 2026

UK00004351617 9 March 2026 (42)

MSK CLONETRACK

International priority date claimed: 15 September 2025 (United States of America) (99392558)

Class 42: Providing scientific research and analysis services in the field of immunology, namely, proprietary methods for analyzing T cell receptor sequencing data for scientific and medical research and health treatment purposes; providing software for analyzing T cell receptor sequences and identifying T cell clonal lineages; bioinformatics services for identifying and tracking T cell populations in connection with monitoring immune response dynamics, endogenous and with therapeutic interventions.

Memorial Sloan-Kettering Cancer Center

Representative: Barker Brettell LLP